Table 2 Comorbidities, medications and ICU data of RIPC and control patients
Variable | Control (N = 17) | RIPC (N = 18) | P-value |
|---|---|---|---|
Comorbidities | Â | Â | Â |
Diabetes mellitus (N) | 3 (17.6%) | 4 (22.2%) | 1.00 |
Hypercholesterolemia (N) | 12 (70.6%) | 9 (50.0%) | 0.31 |
Stroke (N) | 2 (11.8%) | 1 (5.5%) | 0.60 |
Arterial hypertension (N) | 14 (82.3%) | 15 (83.3) | 1.00 |
Myocardial infarction (N) | 3 (17.6%) | 7 (38.8%) | 0.26 |
Medications | Â | Â | Â |
Beta-adrenergic-blockers (N) | 10 (58.8%) | 13 (72.2%) | 0.49 |
ACE/AT-1-antagonists (N) | 11 (64.7%) | 8 (44.4%) | 0.31 |
ASA/clopidogrel (N) | 14 (82.3%) | 13 (72.2%) | 0.69 |
Calcium-channel blockers (N) | 1 (5.9%) | 3 (16.6%) | 0.60 |
Cholesterol-lowering (N) | 8 (47.1%) | 9 (50.0%) | 1.00 |
Insulin/metformin (N) | 2 (11.8%) | 3 (16.6%) | 1.00 |
Diuretics (N) | 5 (29.4%) | 3 (16.6%) | 0.44 |
ICU data | Â | Â | Â |
ICU-stay (hours) | 59 ± 57 | 28 ± 23 | 0.13 |
ICU-readmission (N) | 0 (0%) | 1 (5.5%) | 1.00 |
Reoperation (N) | 1 (5.9%) | 0 (0%) | 0.49 |
Arrythmia (N) | 4 (23.5%) | 7 (38.8%) | 0.47 |
Ventilation time (hours) | 26 ± 25 | 14 ± 5 | 0.15 |
Reintubation (N) | 3 (17.6%) | 1 (5.5%) | 0.34 |